Willow Biosciences (FRA:3D7) Asset Impairment Charge : €0.01 Mil (TTM As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Willow Biosciences Asset Impairment Charge?

Willow Biosciences's Asset Impairment Charge for the three months ended in Dec. 2023 was €0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Dec. 2023 was €0.01 Mil.

Willow Biosciences Asset Impairment Charge Historical Data

The historical data trend for Willow Biosciences's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Willow Biosciences Asset Impairment Charge Chart

Willow Biosciences Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Dec19

Dec20

Dec21

Dec22

Dec23

Asset Impairment Charge

Get a 7-Day Free Trial

21.69

3.95

0.02

0.01

Willow Biosciences Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Asset Impairment Charge	Get a 7-Day Free Trial															-	0.01	-	-	-

Willow Biosciences Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.01 Mil.

Willow Biosciences Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Willow Biosciences's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Willow Biosciences (FRA:3D7) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Willow Biosciences Inc (FRA:3D7) » Definitions » Asset Impairment Charge

Comparable Companies

Traded in Other Exchanges

CANSF:USA WLLW:Canada

Address

202, 1201 5th Street SW, Calgary, AB, CAN, T2R 0Y6

Website

https://www.willowbio.com

Willow Biosciences Inc is a Canadian biotechnology company. It has only one reportable segment engaged in developing and producing high-purity, plant-derived ingredients for consumer care, food and beverage, and pharmaceutical products. Geographically, it derives a majority of its revenue from Canada.

Willow Biosciences (FRA:3D7) Headlines

No Headlines